Elekta Unveils New Neuroscience Solution for Leksell Gamma Knife at AANS

April 16, 2012 — Elekta is revealing innovations for Leksell Gamma Knife Perfexion this week at the 2012 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Miami.

"Once again, AANS will give us the opportunity to demonstrate to neurological surgeons that Gamma Knife radiosurgery is a continually evolving technique," says Jay Hoey, executive vice president, Elekta North America. "The latest example is the capability to exchange information, such as treatment plans, treatment record and protocols, both pre- and post-treatment, putting electronic medical records at your fingertips and allowing you to see all of your treatment statistics in one convenient dashboard. The result is a better flow of patient care and improved use of time and resources."

In addition to the latest product enhancements, Elekta will highlight characteristics of Leksell Gamma Knife Perfexion, including its dedication to intracranial cases, complete solution integration, "shrink-wrap" dose conformity and proven clinical efficacy. Demonstrations of the system will emphasize that Perfexion is designed to minimize risk of human error and radiation toxicity, while optimizing accuracy and dose conformance.

At the meeting Elekta is also exhibiting several other solutions that improve the management of neurological and neurosurgical cases, including:

  • Extend System for frameless, multi-session hypofractionation Gamma Knife radiosurgery;
  • Elekta Neuromag Triux magnetoencephalography (MEG) system;
  • Leksell Stereotactic System for functional neurosurgery; and
  • Leksell SurgiPlan 10, Elekta's image-based neurosurgical planning software specifically designed for the Leksell Stereotactic System.

 

For more information: www.elekta.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now